Page 242 - Aet News Today

Indiana University Health has begun working with healthcare technology company TRIMEDX to test the security of connected medical devices at the health system’s medical device security lab. At the lab, IU Health and TRIMEDX will focus on testing new devices, configurations and security settings, as well as actively scanning medical equipment for security vulnerabilities.

Large employers, particularly self-insured companies, can demand a better and fairer system. They can use their contracting power to insist that their plans cover all FDA approved drugs.

Cresilon, a startup that makes a hemostatic gel to stop bleeding, has raised $25 million in a Series A-4 financing round. The round brings the company's total funding to date to nearly $82 million. The funds will help support Cresilon's entrance into the human health market, as its gel is currently used only by veterinarians.

As digital health gains popularity, the survey provides payers and other healthcare stakeholders with key information on consumers’ preferences when it comes to virtual primary care.

Voice-enabled technology powered by AI reduces documentation time by several hours per week, but physicians won’t adopt a solution unless it’s affordable and intuitive.

The settlement terms are still being negotiated and the final settlement depends on the number of states, counties, and Native American tribes that agree to join

Alkermes says separating cancer from its portfolio and pipeline of neuroscience products could put the company on a path to profitability. Meanwhile, the new cancer company would be an independent and publicly traded entity with a lead immunotherapy in pivotal testing for two types of cancer.

There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems where a majority of cancer care in the US actually occurs. Not enough patients are getting the benefit of precision medicine today. It starts with data sharing and real world evidence.

The seed funding was co-led by Felicis Ventures and SemperVirens. Midi Health will use the $14 million to expand beyond California, form new partnerships and train and hire additional staff.

While the top-level view of the growth in the hospice industry at 20-plus percent is impressive, it’s worth looking at a few prominent examples to gain further insight into this accelerating trend.